WITN5527002 - Patient Agreement Regarding Change to Extended Half Life Products EHL - 19 Apr 2021

Newcastle Haemophilia Centre forms seeking patient agreement for changes to their treatment to Extended Half Life Products EHL in 2016 and Emicizumab Hemlibra in 2019